Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0048 | 1 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |